Guy D, Glicksman R, Buckley R, Cheung P, Chung H, Flax S, et al. Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer. CUAJ [Internet]. 2021 Nov. 18 [cited 2026 Apr. 26];16(4):E220-6. Available from: https://cuaj.ca/index.php/journal/article/view/7525